EQT and Mubadala Agree to Acquire Envirotainer
EQT Private Equity and Mubadala Investment Company are set to acquire Envirotainer, a global provider of temperature-controlled transport solutions for biopharmaceuticals. The deal values the company at approximately EUR 2.8 billion.

EQT Private Equity, through its EQT X fund, and Mubadala Investment Company have agreed to acquire Envirotainer from current owners Cinven and Novo Holdings. Envirotainer is a leading global provider of proprietary temperature-controlled supply chain solutions for transporting biopharmaceuticals.
The transaction values Envirotainer at approximately EUR 2.8 billion. Founded in 1985 and headquartered in Stockholm, Sweden, the company designs, manufactures, and leases active temperature-controlled containers essential for air freighting temperature-sensitive pharmaceutical products. Envirotainer operates a fleet of around 6,700 containers, employs approximately 375 people across 20 countries, and serves over 600 customers, including major global pharmaceutical and biotech firms.
EQT and Mubadala plan to support Envirotainer's future growth by accelerating its expansion, particularly in the Asia-Pacific region, and in its other core markets. The investors intend to scale up the company's recently launched CryoSure offering, invest in new technologies, and continue the rollout of its third-generation Releye platform.
Envirotainer plays a critical role in ensuring the integrity and quality of life-saving pharmaceuticals and vaccines by maintaining precise temperature conditions during transport. The company's solutions are designed to enhance access to vital medicines globally while offering a reduced carbon footprint compared to traditional transportation methods.